Akira and Manulife Launch Virtual Health Care to Canadian Customers
The companies will work together to increase Canadians' ability to be proactive about their health, wherever and whenever they need....
user
International Cannabrands Engages Lemonade Creative and Field Test for Digital D2C Expansion into CBD
DENVER, CO / ACCESSWIRE / May 9, 2019 / International Cannabrands Inc. (CSE: JUJU) (the "Company") is pleased to announce...
DECN Sets Plan to Make Upcoming Patent Infringement Appeal Hearing and Mediation with Johnson & Johnson a Foundation for Substantial Recovery
Company Plans to Build a Foundation for Settlement of All Legal Matters by Wrapping a Legal Settlement into a Wide...
EyeGate Pharma Reports First Quarter 2019 Financial Results and Provides Business Update
WALTHAM, MA / ACCESSWIRE / May 8, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) ("EyeGate" or "the Company") today announced...
Dynatronics Schedules Conference Call to Report Financial Results for Third Fiscal Quarter 2019
COTTONWOOD HEIGHTS, UT / ACCESSWIRE / May 8, 2019 / Dynatronics Corporation (NASDAQ: DYNT), a leading manufacturer of athletic training,...
Artelo Biosciences Retains Crescendo Communications, LLC for Investor Relations Services
Clinical-Stage Biopharmaceutical Company Engages Financial Industry Veteran LA JOLLA, CA / ACCESSWIRE / May 8, 2019 / Artelo Biosciences, Inc....
Top Rated Chiropractor Moves To New And Improved Location In New York, NY
NEW YORK, NY / ACCESSWIRE / May 8, 2019 / Better Health Chiropractic PC is pleased to announce that they...
Medical Technology Playing Vital Role in Early Detection of Heart Attacks Among Younger Women
By Stuart Long, CEO of InfoBionic Improvements in data storage and management, deep learning, artificial intelligence and secure telecommunications have...
Altus Formulation Partners with Evonik to Manufacture its Proprietary SmartCelle Insoluble Drug Delivery Technology
MONTREAL, QC / ACCESSWIRE / May 8, 2019 / SmartCelleTM is Altus Formulation's proprietary polymeric micellar technology for parenteral, oral...
BridgeHead Software appoints David Moysen as Director of IT
Proven IT specialist will oversee global IT infrastructure roadmap and drive organisational performanceASHTEAD, UK – 8 May 2019 – BridgeHead...
EVITRADE Announces Rebranding and Name Change to THERAMED Health Corporation
VANCOUVER, BC / ACCESSWIRE / Tuesday, May 7, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the 'Company')...
Intellipharmaceutics Closes US$1.05 Million Convertible Debenture Financing with Drs. Isa and Amina Odidi
TORONTO, ON / ACCESSWIRE / May 7, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) ("Intellipharmaceutics" or the...
MorphoSys AG Reports First Quarter 2019 Results
Conference call and webcast (in English) to be held on May 8, 2019 at 2:00pm CEST (1:00pm BST/8:00am EDT) -...
Dr. Jan McBarron Offers Support to Individuals Pursuing a Post-Secondary Education in Health-Related Studies
Established doctor and philanthropist Jan McBarron is committed to ensuring that deserving students in the field of health and medicine...
Calidi Biotherapeutics Granted Patent for Cell-Based Oncolytic Virus Immunotherapy for Cancer Treatment
SAN DIEGO, CA / ACCESSWIRE / May 7, 2019 / Calidi Biotherapeutics, Inc. is happy to announce the United States...
EAMSP kicks off information campaign about digitization in German healthcare sector
Fighting the allergic reaction to anything new with #neuschnupfenBrussels, Belgium | Hamburg, Germany, May 7, 2019. While online banking, ordering...
Arcutis, Inc.’s ARQ-151 Development Program for Plaque Psoriasis
ARQ-151 Potential "Best in Class" Topical PDE4 inhibitor ARQ-151 Potentially Only Topical PDE4 inhibitor for Psoriasis Phase 2a Study in...
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / May 7, 2019 / Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its...
International Cannabrands Announces Distribution Deal with Nabis
DENVER, CO / ACCESSWIRE / May 7, 2019 / International Cannabrands Inc. (CSE: JUJU) (the 'Company') is pleased to announce...
Adial Pharmaceuticals Announces Collaboration Agreement with Eurofins for Genetic Biomarker Testing to Support Upcoming Phase 3 Clinical Trial for Alcohol Use Disorder
CHARLOTTESVILLE, VA / ACCESSWIRE / May 7, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com, a clinical-stage biopharmaceutical company...